By downregulating the expression of LINRIS, a prognostic biomarker in CRC, K139 ubiquitination of IGF2BP2 is inhibited, avoiding its degradation via the autophagolysosomal pathway, thereby inhibiting the proliferation of cancer cells [235]. The gene discussed is IGF2BP2; the disease is colorectal carcinoma.